Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer
Clinical trial NCT01505413 · COMPLETED
Trial details
- NCT number
- NCT01505413
- Sponsor
- Soonchunhyang University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.